Leaderboards/Ocular Oncology and Treatments

Ocular Oncology and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Bader Aldughayfiq
Jouf University
2
Ruozhen He
City University of Hong Kong
3
Murtuza Ali Mohammed
Lewis University
4
Rogier J. Nell
Leiden University Medical Center
5
Shiva Sabazade
Karolinska Institutet
6
Shravan Leonard‐Murali
Henry Ford Hospital
7
Charlotte Pandiani
Centre National de la Recherche Scientifique
8
Zheng Zhang
Xidian University
9
Jing Liu
Centre National de la Recherche Scientifique
10
Jacqueline L. Norrie
St. Jude Children's Research Hospital

Papers

1
Physical Layer Security in Near-Field Communications
IEEE Transactions on Vehicular Technology|2024
80 cit.
2
Simultaneous Wireless Information and Power Transfer in Near-Field Communications
IEEE Internet of Things Journal|2024
29 cit.
3
Publication in Ophthalmology Science (2024) [29 citations, W4402037456]
Ophthalmology Science|2024
29 cit.
4
Integrated Sensing and Communications for Pinching-Antenna Systems (PASS)
IEEE Communications Letters|2025
15 cit.
5
Dynamic MIMO Architecture Design for Near-Field Communications
IEEE Transactions on Wireless Communications|2024
14 cit.
6
Near-Field Communications for DMA-NOMA Networks
IEEE Internet of Things Journal|2024
13 cit.
7
Improved Visual Grounding through Self-Consistent Explanations
Unknown Journal|2024
11 cit.
8
Latent epigenetic programs in Müller glia contribute to stress and disease response in the retina
Developmental Cell|2025
11 cit.
9
Publication (2024) [4 citations, W4402158936]
Unknown Journal|2024
4 cit.
10
Layer-Weighted Attention and Ascending Feature Selection: An Approach for Seriousness Level Prediction Using the FDA Adverse Event Reporting System
Applied Sciences|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Odette Mariani
Institut Curie
2
Gustav Stålhammar
Karolinska Institutet
3
Stephen T. Magill
Northwestern University
4
David R. Raleigh
University of California, San Francisco
5
Andrea Forschner
University of Tübingen
6
Katharina C. Kähler
Christian-Albrechts-Universität zu Kiel
7
Alfonso Berrocal-Jaime
Hospital General Universitario De Valencia
8
Ai Zhuang
Shanghai Ninth People's Hospital
9
Lauren A. Dalvin
Mayo Clinic
10
Daniela Göppner
Universitätsklinikum Gießen und Marburg

Papers

1
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Nature Genetics|2022
302 cit.
2
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Nature Medicine|2023
106 cit.
3
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Neuro-Oncology|2022
71 cit.
4
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Nature Genetics|2024
55 cit.
5
Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m <sup>6</sup> A RNA methylation in ocular melanoma
Cancer Communications|2023
39 cit.
6
Radiotherapy and radiosurgery for meningiomas
Neuro-Oncology Advances|2023
36 cit.
7
Intratumor and informatic heterogeneity influence meningioma molecular classification
Acta Neuropathologica|2022
33 cit.
8
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
Cancers|2022
32 cit.
9
Phase 3 study (PIVOTAL) of neoadjuvant intralesional daromun vs. immediate surgery in fully resectable melanoma with regional skin and/or nodal metastases.
Journal of Clinical Oncology|2024
31 cit.
10
Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses
Ophthalmology|2023
30 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Jerry A. Shields
Thomas Jefferson University
2
Carol L. Shields
Thomas Jefferson University
3
J. William Harbour
The University of Texas Southwestern Medical Center
4
Robert A. Weinberg
Whitehead Institute for Biomedical Research
5
Thaddeus P. Dryja
Massachusetts Eye and Ear Infirmary
6
Boris C. Bastian
University of California, San Francisco
7
Brenda L. Gallie
University of Toronto
8
Wen‐Hwa Lee
Universiti Putra Malaysia
9
David H. Abramson
Memorial Sloan Kettering Cancer Center
10
Tero Kivelä
University of Helsinki

Papers

1
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Cell|2008
8.7k cit.
2
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Cell|2004
3.8k cit.
3
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
Cell|2005
3.7k cit.
4
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Nature|2007
3.2k cit.
5
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Nature|1986
3k cit.
6
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Nature|1983
2.9k cit.
7
Distinct Sets of Genetic Alterations in Melanoma
New England Journal of Medicine|2005
2.7k cit.
8
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Cell|2001
2.6k cit.
9
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Nature|2007
2.6k cit.
10
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
Nature Genetics|2008
2.6k cit.

Reagents for Ocular Oncology and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/Dako

Melan A, Melanoma Antigen Recognized by T-Cells

Cited in 6 papers
#M7196
View Evidence →
Agilent/Dako

Melanasome

#M0634
View Evidence →
Cell Signaling TechnologyEvidence 64

PFKP (D2E5) Rabbit Monoclonal Antibody

#12746$161,351
View Evidence →

🌟 All-Time

Most validated

Santa Cruz BiotechnologyEvidence 61

BAP1 (C-4)

Cited in 15 papers
#sc-28383
View Evidence →
Cell Signaling Technology

PathScan® Phospho-S6 Ribosomal Protein (Ser235/236) Sandwich ELISA Kit

Cited in 7 papers
#7205$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 60

Actinomycin D

Cited in 7 papers
#15021$137
View Evidence →